Corrigendum to ‘Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation’ [AUTREV 19-5 (2020) 102507]

Autor:	Mayka Freire, Norberto Ortego-Centeno, A.J. Chamorro, Xavier Pla Salas, Adela Marín Ballvé, José Antonio Vargas Hitos, Carmen Pilar Simeón Aznar, Vicent Fonollosa Pla, Rescle investigators, A. Argibay, Ana Belén Madroñero Vuelta, Luis Sáez Comet, Xavier Corbella, Francisco Hernandez, Andrés García, Sabela Sánchez Trigo, Isabel Perales Fraile, Manuel Rubio-Rivas, Luis Trapiella Martínez, David Bernal Bello, Carles Tolosa Vilella, José Antonio Todolí Parra, Juan José Ríos Blanco, Gerard Espinosa, Rafael Ángel Fernández de la Puebla Giménez, Manuel Ruiz Muñoz, Cristina Gonzalez-Echavarri, Isaac Pons Martín Del Campo, Alfredo Guillén-Del-Castillo, Mónica Rodríguez Carballeira, Dolores Colunga Argüelles, María Esther Sánchez García
Rok vydání:	2021
Předmět:	medicine.medical_specialty Framingham Risk Score business.industry Immunology MEDLINE medicine.disease Scleroderma Internal medicine Cohort Immunology and Allergy Medicine Derivation Internal validation business All cause mortality
Zdroj:	Autoimmunity Reviews. 20:102793
ISSN:	1568-9972
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f447d828dca40d8767d1fb2d0c8fab23 https://doi.org/10.1016/j.autrev.2021.102793 Zobrazit plný text záznamu Full Text from ScienceDirect